Dr. Thomas E. Johnson, MD

Dr. Johnson practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Johnson's NPI, 1477578680, was assigned on July 12, 2006. Dr. Johnson graduated from Carver College of Medicine in 1980. Dr. Johnson holds Florida license ME63708.

Dr. Johnson's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Johnson's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Johnson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Johnson is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Johnson's licenses on file in 4 states: Florida, California, Arizona and Colorado.

Dmand AI lists conjunctivitis, dry eye, eyelid inflammation, hereditary corneal conditions, scleritis and vision problems among the conditions Dr. Johnson treats.

CMS data shows 320 Medicare services from Dr. Johnson across 7 procedure codes in 2024, for 174 Medicare patients. Medicare paid $15,845 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 72, with 66% women.

In 2024, Dr. Johnson wrote 359 Medicare Part D claims for 172 patients. 65% of them were for generic drugs. CMS names the drug for 282 of them, across 6 drugs with 11 or more claims each, at $11,790 in total drug cost. In 2023, CMS named 200 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Johnson for performance year 2024, reported as part of a group. Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Johnson as offering telehealth.

Dmand AI links 291 papers to Dr. Johnson, published from 2005 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Caenorhabditis elegans, Longevity and Aging. Dr. Johnson has published most often in J Gerontol A Biol Sci Med Sci. Dr. Johnson's most frequent co-authors are David T. Tse, MD, Sander R. Dubovy, MD and Kevin Clauss, MD.

CMS Open Payments shows 26 general payments to Dr. Johnson from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $545.

Dmand AI lists 11 awards for Dr. Johnson, most recently Best Doctors in 2013. Dr. Johnson serves on American Society of Ophthalmic Plastic and Reconstructive Surgery.

Dr. Johnson graduated from Carver College of Medicine in 1980. Dr. Johnson is a member of AAO.

Dr. Johnson is in network with 13 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.